Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Large B-cell Lymphoma

Shanghai Ming Ju Biotechnology Co., Ltd. · 2023
ClinicalTrials.gov · Datasets · License: Public Domain · 2023
Open Source ↗
car-t-cellslymphoma
lymphoma, non-hodgkin, diffuse large b cell lymphoma, jwcar029, b-cell malignancies, car t cells, chimeric antigen receptor, relapsed/refractory, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 834525
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.